Being overweight is a risk factor for postmenopausal breast cancer and is associated with an increased incidence and shortened latency of spontaneous and chemically Induced mammary tumors in rodents. However, leptin-deficient obese Lepob Lepob female mice have reduced incidences of spontaneous and oncogene-induced mammary tumors. Of interest, leptin enhances the proliferation of human breast cancer cell lines in which leptin receptors are expressed, which suggests that leptin signaling plays a role in tumor development. We evaluated oncogene-induced mammary tumor development in obese MMTV-TGF-α/Leprdb Leprdb mice that exhibit a defect in OB-Rb, which is considered to be the major signaling isoform of the leptin receptor. Lepr and MMTV-TGF-α mice were crossed, and the offspring were genotyped for oncogene expression and the determination of Lepr status. Lean MMTV-TGF-α/Lepr+ Lepr+ (homozygous) and MMTV-TGF-α/Lepr+ Leprdb (heterozygous) mice and obese MMTV-TGF-α/Leprdb Leprdb mice were monitored until age 104 weeks. Body weights of MMTV-TGF-α/Leprdb Leprdb mice were significantly heavier than those of the lean groups. No mammary tumors were detected in MMTV-TGF-α/LeprdbLeprdb mice, whereas the incidence of mammary tumors in MMTV-TGF-α/Lepr+ Lepr+ and MMTV-TGF-α/Lepr+ Leprdb mice was 69% and 82%, respectively. Examination of mammary tissue whole mounts indicated an absence of duct formation and branching for MMTV-TGF-α/Leprdb Leprdb mice. Both age at mammary tumor detection and tumor burden (tumors/mouse and tumor weights) were similar for the lean genotypes. Serum leptin levels of MMTV-TGF-α/Leprdb Leprdb mice were 12-20-fold higher than levels of lean mice. Thus, despite elevated serum leptin levels, leptin receptor-deficient MMTV-TGF-α/Leprdb Leprdb mice do not develop mammary tumors. This study provides additional evidence that leptin and its cognate receptor may be involved in mammary tumorigenesis.
HuangZHankinsonSEColditzGAStampferMJHunterDJMansonJEHennekensCHRosnerBSpeizerFEWillettWC. Dual effects of weight and weight gain on breast cancer risk. JAMA278:1407–1411, 1997.
2.
NegriELa VecchiaCBruzziPDardanoniGDecarliAPalliDParazziniFRosselli del TurcoM. Risk factors for breast cancer: pooled results from three Italian case-control studies. Am J Epidemiol128:1207–1215, 1988.
3.
La VecchiaCNegriEFranceschiSTalaminiRBruzziPPalliDDecarliA. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer75:441–444, 1997.
4.
ColdSHansenSOvervadKRoseC. A woman's build and the risk of breast cancer. Eur J Cancer34:1163–1174, 1998.
5.
CuiYWhitemanMKLangenbergPSextonMTkaczukKHFlawsJABushTL. Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women?J Womens Health Gend Based Med11: 527–536, 2002.
6.
GearyMPMaihleNJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med216:28–43, 1997.
7.
JohnsonKCPanSMaoY. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev11:253–263, 2002.
8.
MorimotoLMWhiteEChenZChlebowskiRTHaysJKullerLLopezAMMansonJMargolisKLMutiPCStefanickMLMcTiemanA. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control13:741–751, 2002.
9.
StephensonGDRoseDP. Breast cancer and obesity: an update. Nutr Cancer45:1–16, 2003.
10.
WaxierSHTabarPMelcherLP. Obesity and the time of appearance of spontaneous mammary carcinoma in C3H mice. Cancer Res13:276–278, 1953.
11.
WaxierSH. Obesity and cancer susceptibility in mice. Am J Clin Nutr8:760–766, 1960.
12.
SeilkopSK. The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats. Fundam Appl Toxicol24:247–259, 1995.
13.
HasemanJKBourbinaJEustisSL. Effect of individual housing and other experimental design factors on tumor incidence in B6C3F1 mice. Fundam Appl Toxicol23:44–52, 1994.
14.
WolffGLKodellRLCameronAMMedinaD. Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c XVY) F1 hybrid mice. J Toxicol Environ Health10:131–142, 1982.
15.
KlurfeldDMLloydLMWelchCBDavisMJTulpOLKritchevskyD. Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction. Proc Soc Exp Biol Med196:381–384, 1991.
16.
HestonWEVlahakisG. Genetic obesity and neoplasia. J Natl Cancer Inst29:197–209, 1962.
17.
ClearyMPPhillipsFCGetzinSCJacobsonTLJacobsonMKChristensenTAJunejaSCGrandeJPMaihleNJ. Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. Breast Cancer Res Treat77:205–215, 2003.
18.
ZhangYProencaRMaffeiMBaroneMLeopoldLFriedmanJM. Positional cloning of the mouse obese gene and its human homologue. Nature372:425–432, 1994.
19.
HuXJunejaSCMaihleNJClearyMP. Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst94:1704–1711, 2002.
20.
LaudKGourdouIPessemesseLPeyratJPDjianeJ. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol188:219–226, 2002.
21.
DieudonneMNMachinal-QuelinFSerazin-LeroyVLeneveuMCPecqueryRGiudicelliY. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun293:622–628, 2002.
22.
OkumuraMYamamotoMSakumaHKojimaTMaruyamaTJamaliMCooperDRYasudaK. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim Biophys Acta1592:107–116, 2002.
23.
ChenHCharlatOTartagliaLAWoolfEAWengXEllisSJLakeyNDCulpepperJMooreKJBreitbartREDuykGMTepperRIMorgensternJP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell84:491–495, 1996.
24.
TritosNAMantzorosCS. Leptin: its role in obesity and beyond. Diabetologia40:1371–1379, 1997.
25.
MatsuiYHalterSAHoltJTHoganBLCoffeyRJ. Development of mammary hyperplasia and neoplasia in MMTV-TGF α transgenic mice. Cell61:1147–1155, 1990.
HalterSADempseyPMatsuiYStokesMKGraves-DealRHoganBLCoffeyRJ. Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-α. Characterization of mammary gland and skin proliferations. Am J Pathol140:1131–1146, 1992.
28.
SakaiSMizunoMHarigayaTYamamotoKMoriTCoffeyRJNagasawaH. Cause of failure of lactation in mouse mammary tumor virus/human transforming growth factor α transgenic mice. Proc Soc Exp Biol Med205:236–242, 1994.
29.
ClearyMPJacobsonMKPhillipsFCGetzinSCGrandeJPMaihleNJ. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-α female mice. Cancer Epidemiol Biomarkers Prev11:836–843, 2002.
30.
LeeWMLuSMedlineAArcherMC. Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N–methyl-N-nitrosourea. Cancer Lett162:155–160, 2001.
31.
MantzorosCSBolhkeKMoschosSCramerDW. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer80:523–526, 1999.
32.
PetridouEPapadiamantisYMarkopoulosCSpanosEDessyprisNTrichopoulosD. Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control11:383–388, 2000.
33.
TessitoreLVizioBJenkinsODe StefanoIRitossaCArgilesJMBenedettoCMussaA. Leptin expression in colorectal and breast cancer patients. Int J Mol Med5:421–426, 2000.
34.
LiLPriceJEFanDZhangRDBucanaCDFidlerIJ. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst81:1406–1412, 1989.
35.
PriceJE. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat39:93–102, 1996.
36.
AttoubSNoeVPirolaLBruyneelEChastreEMareelMWymannMPGespachC. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. Faseb J14:2329–2338, 2000.
37.
CastellucciMDe MatteisRMeisserACancelloRMonsurroVIslamiDSarzaniRMarzioniDCintiSBischofP. Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod6:951–958, 2000.
38.
GoetzeSBungenstockACzupallaCEilersFStawowyPKintscherUSpencer-HanschCGrafKNurnbergBLawREFleckEGrafeM. Leptin induces endothelial cell migration through Akt, which is inhibited by PPAR9-ligands. Hypertension40:748–754, 2002.
39.
TsuchiyaTShimizuHHorieTMoriM. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol365:273–279, 1999.
40.
GlasowABomsteinSRChrousosGPBrownJWScherbaumWA. Detection of Ob-receptor in human adrenal neoplasms and effect of leptin on adrenal cell proliferation. Horm Metab Res31:247–251, 1999.
41.
GiustiMBoccaLFlorioTCorsaroASpazianteRSchettiniGMinutoF. In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas. Clin Endocrinol (Oxf)57:449–455, 2002.
42.
MixHWidjajaAJandlOCornbergMKaulAGokeMBeilWKuskeMBrabantGMannsMPWagnerS. Expression of leptin and leptin receptor isoforms in the human stomach. Gut47:481–486, 2000.
43.
KonoplevaMMikhailAEstrovZZhaoSHarrisDSanchez-WilliamsGKornblauSMDongJKlicheKOJiangSSnodgrassHREsteyEHAndreeffM. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood93:1668–1676, 1999.
44.
EsteyEThallPKantarjianHPierceSKornblauSKeatingM. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia11:1661–1664, 1997.
45.
WhiteDWKuropatwinskiKKDevosRBaumannHTartagliaLA. Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem272:4065–4071, 1997.
46.
LeeGHProencaRMontezJMCarrollKMDarvishzadehJGLeeJIFriedmanJM. Abnormal splicing of the leptin receptor in diabetic mice. Nature379:632–635, 1996.
47.
ChuaSCJr.ChungWKWu-PengXSZhangYLiuSMTartagliaLLeibelRL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science271:994–996, 1996.
48.
ZabeauLLavensDPeelmanFEyckermanSVandekerckhoveJTavernierJ. The ins and outs of leptin receptor activation. FEBS Lett546:45–50, 2003.
49.
BanksASDavisSMBatesSHMyersMGJr.. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem275:14563–14572, 2000.
50.
GhilardiNZieglerSWiestnerAStoffelRHeimMHSkodaRC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A93:6231–6235, 1996.
51.
MalikKFYoungWSIII. Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology137:1497–1500, 1996.
52.
BjorbaekCUotaniSda SilvaBFlierJS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem272:32686–32695, 1997.
53.
MurakamiTYamashitaTIidaMKuwajimaMShimaK. A short form of leptin receptor performs signal transduction. Biochem Biophys Res Commun231:26–29, 1997.
54.
JinXFukudaNSuJTakagiHLaiYLinZKanmatsuseKWangZWUngerRH. Effects of leptin on endothelial function with OB-Rb gene transfer in Zucker fatty rats. Atherosclerosis169: 225–233, 2003.
55.
MontagueCTFarooqiISWhiteheadJPSoosMARauHWarehamNJSewterCPDigbyJEMohammedSNHurstJACheethamCHEarleyARBarnettAHPrinsJBO'rahillyS. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature387:903–908, 1997.
56.
ClementKVaisseCLahlouNCabrolSPellouxVCassutoDGourmelenMDinaCChambazJLacorteJMBasdevantABougneresPLeboucYFroguelPGuy-GrandB. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature392:398–401, 1998.
57.
ThompsonDBRavussinEBennettPHBogardusC. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet6:675–679, 1997.
58.
MatsuokaNOgawaYHosodaKMatsudaJMasuzakiHMiyawakiTAzumaNNatsuiKNishimuraHYoshimasaYNishiSThompsonDBNakaoK. Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia40:1204–1210, 1997.
59.
GotodaTManningBSGoldstoneAPImrieHEvansALStrosbergADMcKeiguePMScottJAitmanTJ. Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet6:869–876, 1997.
60.
MammesOAubertRBetoulleDPeanFHerbethBVisvikisSSiestGFumeronF. LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest31:398–404, 2001.
61.
QuintonNDLeeAJRossRJEastellRBlakemoreAI. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet108:233–236, 2001.
62.
ChagnonYCWilmoreJHBoreckiIBGagnonJPerusseLChagnonMCollierGRLeonASSkinnerJSRaoDCBouchardC. Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab85:29–34, 2000.
63.
UkkolaOTremblayADespresJPChagnonYCCampfieldLABouchardC. Leptin receptor Gln223Arg variant is associated with a cluster of metabolic abnormalities in response to long-term overfeeding. J Intern Med248:435–439, 2000.
64.
ChungWKBelliKChuaMWileyJMackintoshRNicolsonMBoozerCNLeibelRL. Heterozygosity for Lepob or Lepdb affects body composition and leptin homeostasis in adult mice. Am J Physiol274: R985–R990, 1998.
65.
BatesSHStearnsWHDundonTASchubertMTsoAWWangYBanksASLaveryHJHaqAKMaratos-FlierENeelBGSchwartzMWMyersMGJr.. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature421:856–859, 2003.
